We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
P9‐82: Combination biologic therapy for refractory asthma: A report of two cases.
- Abstract
1 Division of Respiratory Medicine, Department of Medicine, Shiga University of Medical Scien... B Background and Aims b : The widespread use of biologics has resulted in symptom improvement, decreased frequency of exacerbations, and reduction in systemic corticosteroids in many intractable asthmatic patients. Although mepolizumab therapy could control her asthma symptoms and help to taper systemic corticosteroids, her skin symptoms such as itching still strongly remained. Patients having severe asthma and relevant comorbidities might demand actively undergoing treatment that targets multiple biologic pathways.
- Subjects
BIOTHERAPY; ASTHMA; CHURG-Strauss syndrome; ASTHMATICS
- Publication
Respirology, 2021, Vol 26, p394
- ISSN
1323-7799
- Publication type
Article
- DOI
10.1111/resp.14150_783